| Initial public offering of 55,421,123 equity shares of face value of Re. 1 each ("Equity Shares") of Sai Life Sciences Limited (The "Company" or the "Company") for cash at a price of Rs. 549 per equity share (including a premium of Rs. 548 per equity share) ("Offer Price") aggregating to
Rs. 3042.62 crores (the "Offer") comprising a fresh issue of 17,304,189 equity shares of face value of Re. 1 each aggregating to Rs. 950.00 crores (the "Fresh Issue") and an offer for sale of 38,116,934 equity shares of face value of Re. 1 each aggregating to Rs. 2092.62 crores (the "Offer for Sale"), consisting of 6,454,780 equity shares of face value of Re. 1 each aggregating to Rs. 354.37 crores by Sai Qest Syn Private Limited ("Promoter Selling Shareholder"), 23,159,368 equity shares of face value of Re. 1 each aggregating to Rs. 1271.45 crores by tpg asia vii sf pte ltd ("TPG"), 6,210,186 equity shares of face value of Re. 1 each aggregating to
Rs. 340.94 crores by hbm private equity india (collectively with tpg, "Investor Selling Shareholders") and 2,292,600 equity shares of face value of Re. 1 each aggregating to Rs. 125.86 crores by certain persons listed in this prospectus (the "Other Selling Shareholders", as defined below) (the promoter selling shareholder, investor selling shareholders and other selling shareholders, the "Selling Shareholders" and such equity shares, the "Offered Shares").
|
